NAD Press Releases

NAD Recommends AT&T Discontinue Implied Reliability Claims for its Services; AT&T to Appeal

New York, NY – March 14, 2019 – The National Advertising Division has recommended that AT&T Services, Inc. modify or discontinue claims that its DirecTV and U-Verse Internet services are more reliable than cable television and internet services, that cable offers unreliable entertainment, and that cable viewers frequently lose service, following a challenge by Comcast Cable Communications, LLC. NAD is an investigative unit of the advertising industry’s system of self-regulation and is administered by the Council of Better Business Bureaus. Comcast challenged implied claims that...

Read More

NAD Recommends AT&T Modify, Discontinue Certain Reliability Claims for its Services, Finds Certain Claims Supported; AT&T to Appeal

New York, NY –March 4, 2019– The National Advertising Division has recommended that AT&T Services, Inc. modify or discontinue claims that its services deliver 99% reliability following a challenge by Charter Communications, Inc. NAD is an investigative unit of the advertising industry’s system of self-regulation and is administered by the Council of Better Business Bureaus. The challenged claims included, but were not limited to: Express Claims: “Life is too short for unreliable entertainment. Get AT&T Internet and DIRECTV with over 99% reliability for $65 a month for one...

Read More

Procter & Gamble Agrees to Discontinue Claim That Gain Ultra Dish Soap Has “30% More Degreasers vs. Ajax” Following Challenge By Colgate-Palmolive.

New York, NY – Feb. 25, 2019 – The Procter & Gamble Company has agreed to discontinue its claim that its Gain Ultra Dish Soap has “30% More Degreasers vs. Ajax” following a challenge by Colgate-Palmolive Company before the National Advertising Division. NAD is an investigative unit of the advertising industry’s system of self-regulation and is administered by the Council of Better Business Bureaus. Colgate-Palmolive contended that the claim that Gain Ultra Dish Soap has “30% more degreasers vs. Ajax,” made on product packaging and the advertiser’s website, necessarily...

Read More

Procter & Gamble Discontinues Claim that “One Bottle of Dawn Ultra [Dish Soap] has the Grease-Cleaning Power of Three Bottles of [Ajax Ultra]”

New York, NY – Feb. 26, 2019 – The Procter & Gamble Company elected to permanently discontinue its claim that One Bottle of Dawn Ultra has the Grease-Cleaning Power of Three Bottles of Ajax Ultra [“this other liquid”] following a challenge by Colgate-Palmolive Company before the National Advertising Division. NAD is an investigative unit of the advertising industry’s system of self-regulation and is administered by the Council of Better Business Bureaus. The challenged claims included: Express Claims: “One bottle [of Dawn Ultra] has the grease-cleaning power of three bottles...

Read More

National Advertising Division Refers Advertising Claims Made by Nectar Sleep, LLC To Federal Trade Commission.

New York, NY – Feb. 25, 2019 – The National Advertising Division has referred advertising claims made by Nectar Sleep, LLC for its Nectar Mattress to the Federal Trade Commission for further review. The advertiser did not respond to NAD’s requests to provide substantiation for its claims. NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus. The truth and accuracy of the advertiser’s claims was brought to the attention of the NAD by Tuft & Needle, LLC, maker of competing mattresses. The...

Read More

NAD Finds Chattem has Reasonable Basis for Claims that Xyzal Allergy 24 HR is “Nearly Half the Size” of Zyrtec” but Recommended Change to Disclosure

New York, NY – Feb. 20, 2019 –The National Advertising Division has determined that Chattem, Inc. provided a reasonable basis for claims that Xyzal Allergy 24HR is “nearly half the size” of Zyrtec. NAD recommended that the advertiser modify its original “half the size” claim to “nearly half the size” and to modify the accompanying disclaimer to state that the claim is based on the pills’ relative volume or dimensions, and to omit the references to dextrocetirizine in order to more clearly convey the basis for the claim. NAD is an investigative unit of the advertising...

Read More